It has been shown that JAK mutation is correlated with relapse in B-ALL and ~70% of children with JAK mutation carry concomitant deletion of CDKN2A/B and/or IKZF1 (31). This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.